BNP Paribas Put 30 COK 20.12.2024/ DE000PN7DAK3 /
14/05/2024 21:20:25 | Var.-0.090 | Denaro14/05/2024 | Lettera14/05/2024 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.300EUR | -23.08% | 0.300 Quantità in denaro: 12,200 |
0.320 Quantità in lettera: 12,200 |
CANCOM SE O.N. | 30.00 EUR | 20/12/2024 | Put |
GlobeNewswire
03:00
MACROGENICS ALERT: Bragar Eagel & Squire, P.C. is Investigating MacroGenics, Inc. on Behalf of Macro...
GlobeNewswire
03:00
NATERA ALERT: Bragar Eagel & Squire, P.C. is Investigating Natera, Inc. on Behalf of Long-Term Stock...
GlobeNewswire
03:00
XPONENTIAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Xponential Fitness, Inc. on Behalf of...
GlobeNewswire
03:00
PACWEST ALERT: Bragar Eagel & Squire, P.C. is Investigating PacWest Bancorp on Behalf of Long-Term S...
GlobeNewswire
03:00
AVXL ALERT: Bragar Eagel & Squire, P.C. is Investigating Anavex Life Sciences Corp. on Behalf of Lon...
GlobeNewswire
03:00
ARHAUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Arhaus, Inc. on Behalf of Arhaus Stockhol...
GlobeNewswire
03:00
LI AUTO ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Agai...
GlobeNewswire
03:00
EXPENSIFY ALERT: Bragar Eagel & Squire, P.C. is Investigating Expensify, Inc. on Behalf of Long-Term...
GlobeNewswire
03:00
SPROUT SOCIAL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been File...
GlobeNewswire
03:00
INARI ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Agains...
GlobeNewswire
03:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Int...
GlobeNewswire
02:15
Inari Medical, Inc. (NARI) Litigation Initiated After NARI Disclosed DOJ Probe of Business Practices...
GlobeNewswire
02:08
Richtech Robotics Launches Elevator-Enabled Medbot: A Revolutionary Robot to Improve Healthcare Faci...
GlobeNewswire
01:33
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Su...
GlobeNewswire
01:26
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Global Cord Blood Corporation Investors to Secure Co...
GlobeNewswire
01:12
Contact Hagens Berman by May 21, 2024 Deadline to Join Class Action Against Shoals Technologies Grou...
GlobeNewswire
01:09
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel ...